Is non-contrast MRI sufficient to detect meningioma residue after surgery ?
Fiche publication
Date publication
août 2023
Journal
Journal of neuroradiology = Journal de neuroradiologie
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CEBULA Hélène, Pr PROUST François
Tous les auteurs :
Alonso SM, Lersy F, Ardellier FD, Cebula H, Proust F, Onofrei A, Chammas A, Kremer S
Lien Pubmed
Résumé
Contrast-enhanced magnetic resonance imaging (MRI) is the imaging modality routinely used to follow up patients who have undergone surgical resection of brain meningiomas. There are growing concerns about the massive use of gadolinium-based contrast agents (GBCA). Our aim was to evaluate the performance of a new imaging protocol, performed without GBCA injection, in the detection of tumoral residue or local recurrence after surgery of parafalcine and convexity meningiomas.
Mots clés
Gadolinium chelate, MRI, Meningioma, follow-up
Référence
J Neuroradiol. 2023 08 18;: